These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25659761)

  • 21. A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.
    Eaton JE; Juran BD; Atkinson EJ; Schlicht EM; Xie X; de Andrade M; Lammert CS; Luketic VA; Odin JA; Koteish AA; Kowdley KV; Chopra KB; Hirschfield GM; Chalasani NP; Lazaridis KN
    Aliment Pharmacol Ther; 2015 May; 41(10):980-90. PubMed ID: 25783671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of inflammatory bowel disease.
    Burisch J; Munkholm P
    Scand J Gastroenterol; 2015 Aug; 50(8):942-51. PubMed ID: 25687629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
    Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
    Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.
    Stahl K; Klein F; Voigtländer T; Großhennig A; Book T; Müller T; Wree A; Kuellmer A; Weigt J; Dechene A; Wedi E; Kandulski A; Lange CM; Holzwart D; von Witzendorff D; Ringe KI; Wedemeyer H; Heidrich B;
    Trials; 2023 Mar; 24(1):247. PubMed ID: 37004078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging.
    Möller K; Braden B; Culver EL; Jenssen C; Zadeh ES; Alhyari A; Görg C; Ignee A; Hocke M; Dong Y; Sun S; Faiss S; Dietrich CF
    Endosc Ultrasound; 2023; 12(2):181-199. PubMed ID: 36588352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which Suture to Choose in Hepato-Pancreatic-Biliary Surgery? Assessment of the Influence of Pancreatic Juice and Bile on the Resistance of Suturing Materials-In Vitro Research.
    Gierek M; Merkel K; Ochała-Gierek G; Niemiec P; Szyluk K; Kuśnierz K
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bacterial hepatobiliary infections : Pathogen spectrum, antimicrobial resistance and current treatment concepts].
    Bruns T; Stallmach A
    Internist (Berl); 2022 Apr; 63(4):349-366. PubMed ID: 35238985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Gut-Liver Axis in Cholestatic Liver Diseases.
    Blesl A; Stadlbauer V
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Acute Cholangitis Caused by
    Karasawa Y; Kato J; Kawamura S; Kojima K; Ohki T; Seki M; Tagawa K; Toda N
    Gut Liver; 2021 Jul; 15(4):616-624. PubMed ID: 33361547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study.
    Blesl A; Jüngst C; Lammert F; Fauler G; Rainer F; Leber B; Feldbacher N; Stromberger S; Wildburger R; Spindelböck W; Fickert P; Horvath A; Stadlbauer V
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32906634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.
    Martins P; Verdelho Machado M
    GE Port J Gastroenterol; 2020 Feb; 27(2):103-114. PubMed ID: 32266307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic infection facilitates transmission of Pseudomonas aeruginosa in mice.
    Bachta KER; Allen JP; Cheung BH; Chiu CH; Hauser AR
    Nat Commun; 2020 Jan; 11(1):543. PubMed ID: 31992714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial Profiles and Risk Factors of Preexisting Biliary Infection in Patients with Therapeutic Endoscopy.
    Ruan HQ; Liao GL; Peng P; Liu SQ; Wu CL; Qin JF; Liang ZH; Tang GD; Qin MB; Huang JA
    Gastroenterol Res Pract; 2019; 2019():1527328. PubMed ID: 31191641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholangitis: Diagnosis, Treatment and Prognosis.
    Mohammad Alizadeh AH
    J Clin Transl Hepatol; 2017 Dec; 5(4):404-413. PubMed ID: 29226107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.
    Jüngst C; Stadlbauer V; Reichert MC; Zimmer V; Weber SN; Ofner-Ziegenfuß L; Voigtländer T; Spindelböck W; Fickert P; Kirchner GI; Lammert F; Lankisch TO; Krawczyk M
    Sci Rep; 2017 Aug; 7(1):7026. PubMed ID: 28765628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary Sclerosing Cholangitis: a Review of Recent Literature.
    Brooling J; Leal R
    Curr Gastroenterol Rep; 2017 Sep; 19(9):44. PubMed ID: 28752474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study.
    Wobser H; Gunesch A; Klebl F
    BMC Gastroenterol; 2017 Jan; 17(1):10. PubMed ID: 28086796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis.
    Reuken PA; Torres D; Baier M; Löffler B; Lübbert C; Lippmann N; Stallmach A; Bruns T
    PLoS One; 2017; 12(1):e0169900. PubMed ID: 28076388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.